AtriCure cleared to try hybrid atrial fibrillation procedure

AtriCure, the maker of cardiac surgical ablation systems, has received a conditional nod from the FDA to evaluate the safety and efficacy of a hybrid procedure to treat patients with persistent forms of atrial fibrillation. Story